用达克西博胺毒素A成功治疗严重的,控制不良的良性基本血栓
Marissa K Shoji1, Suzan Sargsyan2, Eman Al-Sharif1,3
1Department of Ophthalmology, Shiley Eye Institute, Division of Oculofacial Plastic and Reconstructive Surgery, UC San Diego.
Ophthalmic plastic and reconstructive surgery
|December 10, 2024
概括
达克西胺毒素A为良性基本血栓提供了一个有前途的新疗法,在对其他类型A胺毒素治疗不耐药的患者中显示出延长的持续时间和改善的症状控制.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 良性精髓血栓 (BEB) 涉及非自愿的眼收缩.
- 毒素A型注射是BEB的主要治疗方法.
- 随着时间的推移,一些患者会出现耐药症状或现有治疗疗法的疗效降低.
研究的目的:
- 报告达克西博胺毒素A在患有严重良性基本血栓的患者中的疗效.
- 评估达克西博毒素A作为对其他毒素A型产品无反应的患者的治疗选择.
主要方法:
- 一个57岁男性的案例研究,患有严重的BEB.
- 患者通过周围轨道注射接受了100个单位的达克西博胺毒素A.
- 与之前的治疗方法 (onabotulinumtoxinA,incobotulinumtoxinA) 相比,达西博胺毒素A的疗效的比较.
主要成果:
- 与以前的治疗相比,达西博胺毒素A更快开始和更长的持续时间的主观报告.
- 在注射后3个月,改善了症状管理和50%~75%的疗效保留.
- 与其他甲型肉毒素产品相比,达克西博胺毒素A在这个病人身上显示出更高的疗效.
结论:
- 达克西博胺毒素A可能是对良性基本血栓的有效治疗方法.
- 这种新型药物对那些在现有治疗中症状控制不良的患者有潜力.
- 需要进一步的研究来证实达克西博毒素A在BEB管理中的作用.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
654
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
654
Skeletal Muscle Relaxants: Therapeutic Uses
463
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
463
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Accessory Structures of the Eye
1.5K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.5K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
689
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
689
Open Angle Glaucoma: Treatment
391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
391


